Safety and Efficacy of Nipocalimab in Adults With Generalized Myasthenia Gravis (Vivacity-MG3)

episode

Neurology Minute not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Press Pass | Lawrence on Prep for Patriots' Run Defense, Responding & Building Trust 11 min · 23 Sep 2026 · The Jacksonville Jaguars Official Podcast Network

Iran Enters the War of Words; The AI Agenda for the Trump-Xi Summit 26 min · 23 Sep 2026 · Here's the Scoop

Trump vs. the media 21 min · 23 Sep 2026 · The NPR Politics Podcast

Trump meets Xi: what's at stake? 19 min · 23 Sep 2026 · Business Daily

Musings About the Agentic Future 22 min · 23 Sep 2026 · Motley Fool Hidden Gems Investing

The Reign of Spain 54 min · 23 Sep 2026 · Football Daily

Report any issue

Source

Recorded18 Nov 2025

Publisherneurologyminute.libsyn.com ↗

Handlerec:10217316

Show notes

Dr. Aaron Zelikovich discusses a recent article on nipocalimab and its role in treating generalized myasthenia gravis. Show citations: Antozzi C, Vu T, Ramchandren S, et al. Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2025;24(2):105-116. doi:10.1016/S1474-4422(24)00498-8

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in